Last $7.10 USD
Change Today -0.10 / -1.39%
Volume 9.9K
As of 8:04 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

concord medical - spon adr (CCM) Snapshot

Open
$7.26
Previous Close
$7.20
Day High
$7.27
Day Low
$7.10
52 Week High
03/5/14 - $8.99
52 Week Low
12/2/13 - $4.07
Market Cap
319.1M
Average Volume 10 Days
30.1K
EPS TTM
$0.40
Shares Outstanding
44.9M
EX-Date
08/5/14
P/E TM
17.7x
Dividend
--
Dividend Yield
22.82%
Current Stock Chart for CONCORD MEDICAL - SPON ADR (CCM)

concord medical - spon adr (CCM) Related Bloomberg News

View More Bloomberg News

concord medical - spon adr (CCM) Related Businessweek News

View More BusinessWeek News

concord medical - spon adr (CCM) Details

Concord Medical Services Holdings Limited, through its subsidiaries, operates radiotherapy and diagnostic imaging centers. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy, and diagnostic imaging services. The company also offers other treatments and diagnostic services through the use of medical equipment comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson’s disease; and refraction and tonometry for the diagnosis of ophthalmic conditions. In addition, it provides clinical support services, such as developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, the company offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as is engaged in the sale of medical equipment. The company, through its subsidiaries, holds 52% equity interest in Chang’an Hospital, a non-public general hospital with 1,100 hospital beds located in Xi’an, Shaanxi Province. It also focuses on establishing the Beijing Proton Medical Center that would offer radiotherapy treatment options to cancer patients; and Guangzhou Concord Medical Cancer Hospital, a 400-bed specialty hospital for cancer diagnosis and treatment, as well as other specialty cancer hospitals that would offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of June 30, 2014, it operated a network of 141 centers with 81 hospitals in 56 cities, and 25 provinces and administrative regions in China. The company was founded in 1996 and is headquartered in Beijing, the People’s Republic of China.

608 Employees
Last Reported Date: 04/28/14
Founded in 1996

concord medical - spon adr (CCM) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

concord medical - spon adr (CCM) Key Developments

Concord Medical Services Holdings Limited Receives Government Approvals to Establish Free-Standing Radiotherapy Cancer Center, Datong Meizhong Jiahe Cancer Center in Datong City

Concord Medical Services Holdings Limited announced that the company has received relevant government approvals to establish a free-standing radiotherapy cancer center, Datong Meizhong Jiahe Cancer Center (Datong Center) in Datong City, Shanxi Province. Datong Center, a 100%-owned subsidiary of Concord Medical, will provide advanced, best-practice diagnostic and radiotherapy services with 100 beds once the construction of the facility is completed. It will be the first free-standing center in the Concord Medical network. Construction is expected to begin in November 2014 and the center will be operational in 2015. The center will be registered as a specialty cancer hospital with required departments, including radiation, imaging, test laboratory, inpatient, and nursing. This center will apply to join the local social insurance coverage. This free-standing center facility is an important step of the Company's broader strategy to build a nationwide chain of free-standing cancer treatment and diagnosis centers in the future.

Concord Medical Services Holdings Limited, Board Meeting, Aug 11, 2014

Concord Medical Services Holdings Limited, Board Meeting, Aug 11, 2014.

Concord Medical Services Holdings Limited Reports Unaudited Consolidated Earnings Results for the Second Quarter Ended June 30, 2014; Provides Earnings Guidance for the Year 2014

Concord Medical Services Holdings Limited reported unaudited consolidated earnings results for the second quarter ended June 30, 2014. For the quarter, the company reported total net revenues of RMB 285,300,000 against RMB 254,046,000 a year ago. Operating income was RMB 64,533,000 against RMB 49,175,000 a year ago. Income before income taxes was RMB 57,598,000 against RMB 47,586,000 a year ago. Net income attributable to ordinary shareholders was RMB 34,999,000 or RMB 0.78 per basic and diluted ADS against RMB 29,080,000 or RMB 0.65 per basic and diluted ADS a year ago. Adjusted operating income was RMB 65,519,000 against RMB 51,406,000 a year ago. Adjusted net income was RMB 44,021,000 or RMB 0.89 per basic and diluted ADS against RMB 34,728,000 or RMB 0.70 per basic and diluted ADS a year ago. Adjusted EBITDA was RMB 122,111,000 against RMB 104,302,000 a year ago. Capital expenditure of the network business was RMB 2.5 million for the second quarter of 2014, compared with RMB 24.5 million in the second quarter of 2013. Capital expenditure of the hospital business was RMB 11.1 million compared with RMB 13.3 million for the second quarter of 2013. For the 2014 fiscal year, the company expects earnings in the range of $0.45 to $0.50 per ADS, or $20.3 million to $22.5 million in net income attributable to ordinary shareholders.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CCM:US $7.10 USD -0.10

CCM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Renji Medical Group Ltd/Hong Kong $0.30 HKD -0.005
View Industry Companies
 

Industry Analysis

CCM

Industry Average

Valuation CCM Industry Range
Price/Earnings 19.1x
Price/Sales 1.8x
Price/Book 1.1x
Price/Cash Flow 6.9x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CONCORD MEDICAL - SPON ADR, please visit www.cmsholdings.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.